Review: taking Warfarin sodium and Clonazepam together


Summary

Drug interactions are reported among people who take Warfarin sodium and Clonazepam together. This review analyzes the effectiveness and drug interactions between Warfarin sodium and Clonazepam. It is created by eHealthMe based on reports of 2,920 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Warfarin Sodium

Warfarin sodium has active ingredients of warfarin sodium. It is often used in atrial fibrillation/flutter. (latest outcomes from Warfarin sodium 53,624 users)

Clonazepam

Clonazepam has active ingredients of clonazepam. It is often used in stress and anxiety. (latest outcomes from Clonazepam 60,448 users)

On Sep, 21, 2016

2,920 people who take Warfarin Sodium, Clonazepam are studied.


Number of reports submitted per year:

Warfarin sodium and Clonazepam drug interactions.

Drug effectiveness over time:

Warfarin Sodium:
  • < 1 month: 25.0% - (1 of 4 people)
  • 1 - 6 months: 25.0% - (3 of 12 people)
  • 6 - 12 months: 80.0% - (4 of 5 people)
  • 1 - 2 years: 50.0% - (4 of 8 people)
  • 2 - 5 years: 44.0% - (4 of 9 people)
  • 5 - 10 years: 80.0% - (4 of 5 people)
  • 10+ years: 66.0% - (4 of 6 people)
  • not specified: 0.0% - (0 of 0 people)
Clonazepam:
  • < 1 month: 25.0% - (1 of 4 people)
  • 1 - 6 months: 11.0% - (1 of 9 people)
  • 6 - 12 months: 50.0% - (2 of 4 people)
  • 1 - 2 years: 42.0% - (3 of 7 people)
  • 2 - 5 years: 41.0% - (5 of 12 people)
  • 5 - 10 years: 42.0% - (3 of 7 people)
  • 10+ years: 42.0% - (3 of 7 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Warfarin Sodium:
  • female: 48.0% - (13 of 27 people)
  • male: 50.0% - (11 of 22 people)
Clonazepam:
  • female: 39.0% - (11 of 28 people)
  • male: 31.0% - (7 of 22 people)

Drug effectiveness by age:

Warfarin Sodium:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 1 people)
  • 30-39: 33.0% - (2 of 6 people)
  • 40-49: 50.0% - (5 of 10 people)
  • 50-59: 60.0% - (6 of 10 people)
  • 60+: 50.0% - (11 of 22 people)
Clonazepam:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 1 people)
  • 30-39: 33.0% - (2 of 6 people)
  • 40-49: 45.0% - (5 of 11 people)
  • 50-59: 33.0% - (3 of 9 people)
  • 60+: 34.0% - (8 of 23 people)

Most common drug interactions over time *:

< 1 month:
  • international normalised ratio increased
  • anxiety
  • depression
  • pain
  • fall
  • headache
  • international normalised ratio decreased
  • nausea
  • anal cancer
  • aplasia pure red cell
1 - 6 months:
  • haemorrhage
  • cardiac failure congestive
  • malaise
  • nausea
  • international normalised ratio increased
  • pain
  • cough
  • fatigue
  • gastrointestinal haemorrhage
  • gastrooesophageal reflux disease
6 - 12 months:
  • petechiae
  • transient ischaemic attack
  • depression
  • thrombosis
  • balance disorder
  • bleeding time shortened
  • blood creatine phosphokinase increased
  • cardiac arrest
  • cerebrovascular accident
  • chills
1 - 2 years:
  • depression
  • emotional distress
  • hypersexuality
  • obsessive-compulsive personality disorder
  • pathological gambling
  • suicidal ideation
  • cholecystitis acute
  • haematoma
  • pneumonia
  • septic shock
2 - 5 years:
  • dental caries
  • drooling
  • enamel anomaly
  • oral pain
  • tooth extraction
  • tooth fracture
  • toothache
  • diarrhoea
  • subdural haematoma
  • abdominal wall haematoma
5 - 10 years:
  • headache
  • suicidal ideation
  • confusional state
  • bradykinesia
  • bradyphrenia
  • hysterectomy
  • nephrogenic systemic fibrosis
  • anhedonia
  • anxiety
  • emotional distress
10+ years:
  • transient ischaemic attack
  • depression
  • skin blushing/flushing
  • abdominal pain
  • anhedonia
  • anxiety
  • anxiety and stress
  • anxiety, apprehension, feeling uptight, jitters, stress, stress and anxiety, tension
  • asthma late onset
  • atrial fibrillation aggravated
not specified:
  • pain
  • anxiety
  • dyspnoea
  • fatigue
  • nausea
  • fall
  • depression
  • pneumonia
  • headache
  • arthralgia

Most common drug interactions by gender *:

female:
  • pain
  • anxiety
  • dyspnoea
  • nausea
  • fatigue
  • headache
  • depression
  • fall
  • pneumonia
  • arthralgia
male:
  • pain
  • anxiety
  • dyspnoea
  • fatigue
  • fall
  • atrial fibrillation
  • nausea
  • anaemia
  • pneumonia
  • dizziness

Most common drug interactions by age *:

0-1:
  • deep vein thrombosis
  • neuroleptic malignant syndrome
  • pulmonary embolism
  • suicide attempt
  • systemic lupus erythematosus
  • type 2 diabetes mellitus
2-9:
  • renal impairment
  • alanine aminotransferase increased
  • aspartate aminotransferase increased
  • blood creatine phosphokinase increased
  • circulatory collapse
  • haemoglobin decreased
  • hepatic function abnormal
  • large intestine perforation
  • malaise
  • neuroleptic malignant syndrome
10-19:
  • anaemia
  • anxiety
  • arthralgia
  • back pain
  • bronchitis
  • contusion
  • cough
  • dyspnoea
  • dyspnoea exertional
  • gastrooesophageal reflux disease
20-29:
  • fatigue
  • nausea
  • insomnia
  • upper respiratory tract infection
  • cardiac failure congestive
  • pain
  • vomiting
  • bronchitis
  • influenza like illness
  • sinusitis
30-39:
  • nausea
  • pain
  • neuroleptic malignant syndrome
  • circulatory collapse
  • headache
  • renal impairment
  • hepatic function abnormal
  • sepsis
  • anxiety
  • back pain
40-49:
  • fatigue
  • pain
  • pneumonia
  • headache
  • dyspnoea
  • weight decreased
  • anxiety
  • gastrooesophageal reflux disease
  • anaemia
  • nausea
50-59:
  • pain
  • anxiety
  • fatigue
  • depression
  • fall
  • dyspnoea
  • nausea
  • pyrexia
  • arthralgia
  • headache
60+:
  • pain
  • fall
  • nausea
  • dyspnoea
  • atrial fibrillation
  • anxiety
  • international normalised ratio increased
  • oedema peripheral
  • dizziness
  • fatigue

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Warfarin sodium and Clonazepam?


Recent conversations of related support groups:

Can you answer these questions?

More questions for: Warfarin sodium, Clonazepam

You may be interested in these reviews

More reviews for: Warfarin sodium, Clonazepam

On eHealthMe, Warfarin sodium (warfarin sodium) is often used to treat atrial fibrillation/flutter. Clonazepam (clonazepam) is often used to treat stress and anxiety. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.